| |  | | Saturday, November 2, 2019 | How You Can Profit from Silicon Valley's Health Tech Obsession
|  | Dear Startup Investor,
2019 has been a banner year for healthcare startups.
Dozens of new companies are tackling huge problems that affect millions of people, like infertility, anxiety, and cancer.
Just this week, "femtech" startup Inne announced an $8.8 million VC funding round. Its mission? To help women predict and track their fertility cycles using a saliva-testing device and a smartphone app. Meanwhile, a pharmacy startup called Capsule landed a $200 million series C round; and a healthcare analytics company called Socially Determined locked in $7.3 million in funding.
These stories are absolutely everywhere this year, and I couldn't be more excited about it. For starters, these companies have missions that could change peoples' lives for the better.
But there's also huge profit potential here. After all, companies like these have a built-in audience. An invention that saves lives in a novel way has virtually unlimited upside.
Just the other day, a colleague of mine told me an absolutely incredible story about just such an invention. He's a Silicon Valley veteran who always knows what the next huge thing is going to be.
This time, he was all worked up about a new healthcare innovation that's set to take the world by storm. It's called "cryogenic blood," and it's changing the way we treat everything from wounds to blood disorders to cancer and beyond.
He told me stories about the tech that were so unbelievable, I had to look them up and verify them myself.
The crazy thing is... they're all true.
Like the First Lieutenant who was wounded by an IED explosion in Afghanistan. He had horrific lacerations and was seconds away from death... Until army medics gave him an injection of cryogenic blood.
Suddenly, his wounds began closing all on their own. His body started to heal itself, then and there, eliminating the need for intensive surgery.
I know - it's absolutely unbelievable... And yet it's 100% true.
Some of the world's top medical researchers are working to perfect this technology for widespread use. Cryogenic blood has the potential to save millions of lives - and pretty soon, it'll be the new standard of care for traumatic injuries in the U.S.
But my friend let me in on a little secret...
There's only one company out there making this specialized type of cryogenic blood. And when this tech hits the market, this company's revenues could skyrocket exponentially... And its investors could become millionaires.
I want you to be one of them. Just click here to learn more.
Until next time,
Neil | | | Trending | | | | | | | | Stay Connected | | | Please do not reply to this email. It was sent from an unmonitored mailbox.
You are receiving this e-mail at phanphuongthanh89.822152@blogger.com, as part of your subscription to The Startup Investor. To remove your email from this list: Unsubscribe here.
To cancel, or for any other questions or requests, please contact our Customer Service team:
Online
Phone: 866-310-1498 (North America) 410-501-5876 (International)
Mail: The Startup Investor| Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201
Fax: 410-713-4352
Our Customer Service team is available Monday - Friday between 9:00 AM and 5:00 PM ET.
© 2019 Angels & Entrepreneurs, LLC. All Rights Reserved.
Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs, LLC. 1125 N Charles Street, Baltimore MD 21201.
Website | Privacy Policy | Terms & Conditions | |
No comments:
Post a Comment